Cognitive and brain function in schizotypal personality disorder

Schizophrenia Research

Volumn 54, Issue 1-2, 2002, Pages 157-167

  Siever, Larry J ^a,c   Koenigsberg, Harold W ^a,b   Harvey, Philip ^a,b   Mitropoulou, Vivian ^a   Laruelle, Marc ^b   Abi Dargham, Anissa ^b   Goodman, Marianne ^a,b   Buchsbaum, Monte ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cognitive function; Schizophrenia; Schizotypal personality disorder

Indexed keywords

AMPHETAMINE; CATECHOLAMINE DERIVATIVE; DEOXYGLUCOSE; FLUORODEOXYGLUCOSE; HOMOVANILLIC ACID; N [(1 ETHYL 2 PYRROLIDINYL)METHYL] 3 IODO 6 METHOXYSALICYLAMIDE; NEUROTRANSMITTER; RISPERIDONE;

ATTENTION; BLOOD LEVEL; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN SIZE; COGNITION; CONFERENCE PAPER; DISEASE SEVERITY; DOPAMINERGIC ACTIVITY; ELECTROENCEPHALOGRAM; FRONTAL CORTEX; HUMAN; IMAGING; INFORMATION PROCESSING; LEARNING; NEUROANATOMY; NEUROCHEMISTRY; PERSONALITY DISORDER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PULVINAR; SCHIZOPHRENIA; SENSORY CORTEX; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TASK PERFORMANCE; TEMPORAL LOBE; THALAMUS DORSOMEDIAL NUCLEUS; THALAMUS NUCLEUS; VERBAL BEHAVIOR; WORKING MEMORY;

BENZAMIDES; BRAIN; COGNITION DISORDERS; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROPSYCHOLOGICAL TESTS; PYRROLIDINES; SCHIZOTYPAL PERSONALITY DISORDER; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036499038     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00363-2     Document Type: Conference Paper

References (93)

1. Neuropsychological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia
2. Familial relatedness of schizophrenia and schizotypal stats
3. A family study of schizotypal disorder
4. The factor structure of schizotypal symptoms in a clinical population
5. Verbal learning and memory in schizotypal personality disorder
6. Schizotypal symptoms in the relatives of schizophrenia patients: An empirical analysis of the factor structure
7. P300 event-related potential abnormalities in borderline personality disorder
8. Impaired speed of information processing in nonmedicated schizotypal patients
9. Information processing and attention dysfunctions in schizophrenia
10. Sensorimotor gating and schizophrenia: Human and animal model studies
11. Effects of metabolic perturbation on plasma homovanillic acid in schizophrenia
12. Regional cerebral blood flow during the Wisconsin Card Sort Test in schizotypal personality disorder
13. Ventricular volume and assymetry in schizotypal personality disorder and schizophrenia assessed with magnetic resonance imaging
14. Prefrontal and temporal metabolic rates in schizophrenia and schizotypal personality disorder
15. Magnetic resonance imaging of the thalamic mediodorsal nuclei and pulvinar in schizophrenia and schizotypal personality disorder
16. Impaired startle prepulse inhibition and habituation in schizotypal patients
17. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder
18. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorders: Evidence of inhibitory deficits
19. Cerebral structural abnormalities in schizophreniform disorder and in schizophrenia spectrum personality disorders
20. Schizophrenic deficits in the processing of context: Converging evidence from three theoretically motivated cognitive tasks
21. Global attentional deviance as a marker of risk for schizophrenia: Specifically and predictive validity
22. Childhood attentional dysfunctions predict social deficits in unaffected adults at risk for schizophrenia
23. Dopamine and schizophrenia: A reconceptualization
24. Attention, startle eye-blink modification, and psychosis proneness
25. Schizotypal personality disorder and MRI abnormalities of temporal lobe gray matter
26. Large CSF volumes not attributable to ventricular volume in schizotypal personality disorder
27. Shape and size of the corpus callosum in schizophrenia and schizotypal personality disorder
28. Temporal lobe volume determined by magnetic resonance imaging in schizotypal personality disorder and schizophrenia
29. Visual perception and working memory in schizotypal personality disorder
30. Pharmacologic strategies for augmenting cognitive performance in schizophrenia
31. Frontal cortex dysfunction and subcortical dopaminergic activity in schizophrenia spectrum
32. Dual-task performance operating characteristics, resource limitations, and automatic processing in schizophrenia
33. The search for a schizotype: Crossing the border again
34. Information processing markers of vulnerability to schizophrenia: Performance of patients with schizotypal and non-schizotypal personality disorders
35. Three-dimensional analysis with MRI and PET of the size, shape and function of the thalamus in the schizophrenia spectrum
36. Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia
37. An independent analysis of the Copenhagen sample of the Danish adoption study of schizophrenia
38. The structure of schizotypy: A pilot multitrait twin study
39. The Roscommon family study: I. Methods, diagnosis of probands and risk of schizophrenia in relatives
40. The effect of family status and schizotypy on electrophysiological measures of attention and semantic processing
41. Effects of amphetamine on visuospatial working memory performance in schizophrenia spectrum personality disorder
42. Topography of the auditory P300 in schizotypal personality
43. Subcortical dopaminergic activity in schizotypal personality disorder
44. Risperidone in the treatment of schizotypal personality disorder
45. Auditory P300 does not differentiate borderline personality disorder from schizotypal personality disorder
46. MRI study of cavum septum pellucidi in schizophrenia, affective disorder and schizotypal personality disorder
47. Schizotypal traits, attention and eye movements
48. Visuospatial working memory in schizotypal personality disorder patients
49. Impaired eye tracking in undergraduates with schizotypal personality disorder
50. Schizotypy and sustained attention
51. Psychometric high-risk paradigm, perceptual aberrations, and schizotypy
52. Eye tracking and schizophrenia: A critical review
53. Human and animal studies of schizophrenia-related gating deficits
54. Impaired cognitive functioning in symptomatic volunteers with schizotypy: Preliminary findings
55. Auditory P300 abnormalities and left posterior superior temporal gyrus voluume reduction in schizophrenia
56. Uniting Kraepelin and Bleuler: The psychology of schizophrenia and the biology of temporal lobe abnormalities
57. Schizophrenia Spectrum Disorders: Electrophysiological and Structural MRI Features
58. Schizotypal personality disorder chestnut Lodge follow-up study: VI. Long-term follow-up perspective
59. Backward masking spatial frequency effects among hypothetically schizotypal individuals
60. Signal detection in vigilance tasks and behavioral attributes among offspring of schizophrenic mothers and among hyperactive children
61. Electrophysiological correlates of language processing in schizotypal personality disorder
62. Lateralized P3 deficit in schizotypal personality disorder
63. Antisaccades and smooth pursuit eye tracking and schizotypy
64. Clinical applications of PS component of event-related potentials: II. Dementia, depression and schizophrenia
65. PS in Schizophrenia is affected by stimulus modality, response requirements, medication status, and negative symptoms
66. Longitudinal measurement of plasma homovanillic acid in schizophrenic patients: Correlation with psychosis and response to neuroleptic treatment
67. Prefrontal structural and functional deficits associated with individual differences in schizotypal personality
68. Cognitive-perceptual, interpersonal, and disorganized features of schizotypal personality
69. Attentional functioning in schizotypal personality disorder
70. A continuous performance test of brain damage
71. Event-related potentials in schizophrenics
72. Auditory event-related potentials in schizophrenia and depression
73. Auditory evoked response, EEG, and thought processes in schizophrenics
74. Diagnoses of the relatives of schizotypal outpatients
75. Striatal size and glucose metabolic rate in schizotypal personality disorder and schizophrenia
76. D-amphetamine challenge effects on Wisconsin Card Sort Test performance in schizotypal personality disorder
77. A psychobiological perspective on the personality disorders
78. Smooth pursuit eye movements in non-psychiatric populations: Relationship to other "markers" for schizophrenia and psychological correlates
79. Impaired smooth-pursuit eye movement: Vulnerability marker for schizotypal personality disorder in a normal volunteer population
80. Clinical psychophysiologic and neurologic characteristics of volunteers with impaired smooth pursuit eye movements
81. Eye tracking impairment in clinically identified schizotypal personality disorder patients
82. Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients
83. Eye movement impairment and schizotypal psychopathology
84. The boundaries of schizophrenia
85. Lateral ventricle enlargement in schizotypal personality disorder
86. Lateral ventricular enlargement in schizophrenic probands and their siblings with schizophrenia-related disorders
87. Smooth pursuit eye movements in subjects reporting physical anhedonia and perceptual aberrations
88. Cognitive abnormalities in schizophrenic patients and schizotypal college students
89. Plasma homovanilic acid as an index of brain dopaminergic metabolism: Enhancement with debrisoquin
90. Treatment of personality disorders
91. Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder
92. Neuropsychological dysfunction in schizotypal personality disorder: A profile analysis
93. Verbal and nonverbal neuropsychological test performance in subjects with schizotypal personality disorder